Pediatric Neuroblastoma Treatment Market Report

Global and Region Pediatric Neuroblastoma Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：165
  • REPORT CODE：GMM1000736
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Pediatric Neuroblastoma Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Pediatric Neuroblastoma Treatmentmarket, defines the market attractiveness level of Pediatric Neuroblastoma Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Pediatric Neuroblastoma Treatment industry, describes the types of Pediatric Neuroblastoma Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pediatric Neuroblastoma Treatment market and the development prospects and opportunities of Pediatric Neuroblastoma Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pediatric Neuroblastoma Treatment market in Chapter 13.

    By Player:

    • Cellectar Biosciences

    • Apeiron Biologics

    • United Therapeutics

    • MacroGenics

    • Bayer

    • Baxter

    • Pfizer

    By Type:

    • Immunotherapy

    • Chemotherapy

    • Others

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Pediatric Neuroblastoma Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Pediatric Neuroblastoma Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Pediatric Neuroblastoma Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Pediatric Neuroblastoma Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Pediatric Neuroblastoma Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Pediatric Neuroblastoma Treatment Consumption (2017-2022)

    • 7.2 United States Pediatric Neuroblastoma Treatment Consumption (2017-2022)

    • 7.3 Europe Pediatric Neuroblastoma Treatment Consumption (2017-2022)

    • 7.4 China Pediatric Neuroblastoma Treatment Consumption (2017-2022)

    • 7.5 Japan Pediatric Neuroblastoma Treatment Consumption (2017-2022)

    • 7.6 India Pediatric Neuroblastoma Treatment Consumption (2017-2022)

    • 7.7 South Korea Pediatric Neuroblastoma Treatment Consumption (2017-2022)

    8 Region and Country-wise Pediatric Neuroblastoma Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Pediatric Neuroblastoma Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Pediatric Neuroblastoma Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Pediatric Neuroblastoma Treatment Consumption Forecast (2022-2028)

    • 8.4 China Pediatric Neuroblastoma Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Pediatric Neuroblastoma Treatment Consumption Forecast (2022-2028)

    • 8.6 India Pediatric Neuroblastoma Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Pediatric Neuroblastoma Treatment Consumption Forecast (2022-2028)

    9 Global Pediatric Neuroblastoma Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Pediatric Neuroblastoma Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Immunotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pediatric Neuroblastoma Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Pediatric Neuroblastoma Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Pediatric Neuroblastoma Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Pediatric Neuroblastoma Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Pediatric Neuroblastoma Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Pediatric Neuroblastoma Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Pediatric Neuroblastoma Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Pediatric Neuroblastoma Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Pediatric Neuroblastoma Treatment Market Competitive Analysis

    • 14.1 Cellectar Biosciences

      • 14.1.1 Cellectar Biosciences Company Details

      • 14.1.2 Cellectar Biosciences Pediatric Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Cellectar Biosciences Pediatric Neuroblastoma Treatment Product and Service

    • 14.2 Apeiron Biologics

      • 14.2.1 Apeiron Biologics Company Details

      • 14.2.2 Apeiron Biologics Pediatric Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Apeiron Biologics Pediatric Neuroblastoma Treatment Product and Service

    • 14.3 United Therapeutics

      • 14.3.1 United Therapeutics Company Details

      • 14.3.2 United Therapeutics Pediatric Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 United Therapeutics Pediatric Neuroblastoma Treatment Product and Service

    • 14.4 MacroGenics

      • 14.4.1 MacroGenics Company Details

      • 14.4.2 MacroGenics Pediatric Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 MacroGenics Pediatric Neuroblastoma Treatment Product and Service

    • 14.5 Bayer

      • 14.5.1 Bayer Company Details

      • 14.5.2 Bayer Pediatric Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bayer Pediatric Neuroblastoma Treatment Product and Service

    • 14.6 Baxter

      • 14.6.1 Baxter Company Details

      • 14.6.2 Baxter Pediatric Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Baxter Pediatric Neuroblastoma Treatment Product and Service

    • 14.7 Pfizer

      • 14.7.1 Pfizer Company Details

      • 14.7.2 Pfizer Pediatric Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Pfizer Pediatric Neuroblastoma Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Pediatric Neuroblastoma Treatment

    • Figure Pediatric Neuroblastoma Treatment Picture

    • Table Global Pediatric Neuroblastoma Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pediatric Neuroblastoma Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pediatric Neuroblastoma Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Pediatric Neuroblastoma Treatment Consumption by Country (2017-2022)

    • Figure United States Pediatric Neuroblastoma Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Pediatric Neuroblastoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Pediatric Neuroblastoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Pediatric Neuroblastoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Pediatric Neuroblastoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pediatric Neuroblastoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Pediatric Neuroblastoma Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Pediatric Neuroblastoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pediatric Neuroblastoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Pediatric Neuroblastoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pediatric Neuroblastoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pediatric Neuroblastoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pediatric Neuroblastoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Pediatric Neuroblastoma Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Pediatric Neuroblastoma Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Cellectar Biosciences (Foundation Year, Company Profile and etc.)

    • Table Cellectar Biosciences Pediatric Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cellectar Biosciences Pediatric Neuroblastoma Treatment Product and Service

    • Table Apeiron Biologics (Foundation Year, Company Profile and etc.)

    • Table Apeiron Biologics Pediatric Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apeiron Biologics Pediatric Neuroblastoma Treatment Product and Service

    • Table United Therapeutics (Foundation Year, Company Profile and etc.)

    • Table United Therapeutics Pediatric Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table United Therapeutics Pediatric Neuroblastoma Treatment Product and Service

    • Table MacroGenics (Foundation Year, Company Profile and etc.)

    • Table MacroGenics Pediatric Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table MacroGenics Pediatric Neuroblastoma Treatment Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Pediatric Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Pediatric Neuroblastoma Treatment Product and Service

    • Table Baxter (Foundation Year, Company Profile and etc.)

    • Table Baxter Pediatric Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter Pediatric Neuroblastoma Treatment Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Pediatric Neuroblastoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Pediatric Neuroblastoma Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US